Related Experiment Video
Updated: Mar 3, 2026
09:10
Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
Published on: January 7, 2022
2.8K
Solithromycin: A novel ketolide antibiotic
Michael J Buege1, Jack E Brown2,3, Samuel L Aitken4,5
1Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston, TX.
Summary
Solithromycin, a novel ketolide antibiotic, shows promise for community-acquired bacterial pneumonia (CABP) but faces regulatory hurdles due to potential liver injury and infusion-site reactions.
Area of Science:
- Pharmacology and Infectious Diseases
- Antibiotic Development and Clinical Trials
Background:
- Solithromycin is a novel ketolide antibiotic designed for treating community-acquired bacterial pneumonia (CABP).
- It exhibits broad-spectrum activity against intracellular organisms, including macrolide-resistant strains.
Purpose of the Study:
- To review the pharmacology, pharmacokinetics, pharmacodynamics, antimicrobial activity, clinical safety, and regulatory status of solithromycin.
- To assess solithromycin's efficacy and safety in treating moderately severe CABP.
Main Methods:
- Review of existing literature on solithromycin's properties and clinical trial data.
- Analysis of Phase III clinical trial results comparing solithromycin with moxifloxacin for CABP treatment.
Main Results:
- Solithromycin demonstrated noninferiority to moxifloxacin in 5-7 day oral and IV-to-oral regimens for CABP.
- Infusion-site reactions occurred in nearly one-third of IV solithromycin recipients.
- Transient, asymptomatic transaminitis was observed more frequently with IV-to-oral solithromycin compared to moxifloxacin.
Conclusions:
- Solithromycin possesses favorable pharmacological and antimicrobial properties for CABP treatment.
- Concerns regarding drug-induced liver injury and infusion-site reactions have impacted its regulatory approval.
- Further large-scale studies are recommended to fully characterize solithromycin's safety profile, particularly hepatotoxicity.
More Related Videos
Related Concept Videos
01:27Combined Effects of Drugs: Synergism
7.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.1K
01:16Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
1.7K
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.7K
00:57Antibiotic Selection
61.6K
Overview
61.6K
01:22Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
234
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
234
01:28Pulmonary Tuberculosis V
697
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
697
01:23Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
58
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s...
58